Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rimostil

This article was originally published in The Tan Sheet

Executive Summary

Novogen expects nationwide distribution of isoflavone menopause supplement for "bone and heart health in women" to be completed within the next several months. The product currently is available in health food stores around San Francisco. One tablet contains 57 mg of Clovone, a proprietary blend of the isoflavones fomononetin, daidzein, biochanin A and genistein. Suggested retail price for a 28-day supply of Rimostil is $29.95. Novogen also markets Promensil for perimenopausal women and Trinovin for prostate health
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS092318

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel